HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19

SARS‐CoV‐2 infection results in different outcomes ranging from asymptomatic infection to mild or severe disease and death. Reasons for this diversity of outcome include differences in challenge dose, age, gender, comorbidity and host genomic variation. Human leukocyte antigen (HLA) polymorphisms ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Astbury, Stuart, Reynolds, Catherine J., Butler, David K., Muñoz‐Sandoval, Diana C., Lin, Kai‐Min, Pieper, Franziska P., Otter, Ashley, Kouraki, Afroditi, Cusin, Lola, Nightingale, Jessica, Vijay, Amrita, Craxford, Simon, Aithal, Guruprasad P., Tighe, Patrick J., Gibbons, Joseph M., Pade, Corinna, Joy, George, Maini, Mala, Chain, Benny, Semper, Amanda, Brooks, Timothy, Ollivere, Benjamin J., McKnight, Áine, Noursadeghi, Mahdad, Treibel, Thomas A., Manisty, Charlotte, Moon, James C., Valdes, Ana M., Boyton, Rosemary J., Altmann, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111350/
https://www.ncbi.nlm.nih.gov/pubmed/35156709
http://dx.doi.org/10.1111/imm.13450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111350/
https://www.ncbi.nlm.nih.gov/pubmed/35156709
http://dx.doi.org/10.1111/imm.13450

Ejemplares similares